Latest period
$1.70M
YoY change
-38.1%
5Y CAGR
-9.5%
Peak year (2022)
$4.84M
Latest annual
$2.32M
Stock-Based Compensation history chart for Equillium (EQ) from 2017 to 2025
Latest: $2.32M
Stock-Based Compensation growth chart for Equillium (EQ) from 2017 to 2025
Latest: -38.1%
Stock-Based Compensation history table for Equillium (EQ) from 2017 to 2025
| 2025 | $2.32M | -38.1% | −$1.43M | ||
| 2024 | $3.75M | -6.2% | −$247.00K | ||
| 2023 | $4.00M | -17.4% | −$844.00K | ||
| 2022 | $4.84M | +9.8% | +$431.00K | ||
| 2021 | $4.41M | +15.5% | +$593.00K | ||
| 2020 | $3.82M | +69.5% | +$1.56M | ||
| 2019 | $2.25M | +409.6% | +$1.81M | ||
| 2018 | $441.91K | — | +$441.91K | ||
| 2017 | $0.00 | — | — |
- 2025$2.32M-38.1%
- 2024$3.75M-6.2%
- 2023$4.00M-17.4%
- 2022$4.84M+9.8%
- 2021$4.41M+15.5%
- 2020$3.82M+69.5%
- 2019$2.25M+409.6%
- 2018$441.91K—
- 2017$0.00—
Stock-Based Compensation values are taken from Equillium's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Equillium (EQ)
Stock-Based Compensation for Equillium (EQ): headline value $1.70M · YoY -38.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual stock-based compensation for Equillium (EQ) came in at $2.32M – plunged 38.1% year-over-year.
Across 2020–2025 (5 years), Equillium stock-based compensation produced a CAGR of -9.5% – with a net decline across the window.
2022 marks the peak stock-based compensation at $4.84M, with the historical low of $0.00 recorded in 2017.
Equillium Stock-Based Compensation by Year
Equillium Stock-Based Compensation 2025: $2.32M
2025's stock-based compensation for Equillium came in at $2.32M, plunged 38.1% below 2024.
Equillium Stock-Based Compensation 2024: $3.75M
Equillium posted stock-based compensation of $3.75M in 2024, declined 6.2% below 2023.
Equillium Stock-Based Compensation 2023: $4.00M
In 2023, Equillium reported stock-based compensation of $4.00M, declined 17.4% below 2022.
Equillium Stock-Based Compensation 2022: $4.84M
Equillium stock-based compensation in 2022 was $4.84M, grew 9.8% from 2021. This figure represents the highest annual value in the available history.
Equillium Stock-Based Compensation 2021: $4.41M
Equillium stock-based compensation in 2021 was $4.41M.
See more financial history for Equillium (EQ).
Sector peers by Stock-Based Compensation
Healthcare peers of Equillium (EQ), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Equillium (EQ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation